Lipödemde Patofizyolojik Mekanizmalar-Hormonal ve Genetik Mekanizmalar

Poojari A, Dev K, Rabiee A. Lipedema: Insights into Morphology, Pathophysiology, and Challenges. Biomedicines. 2022;10(12):3081.

Mortada H, Alhithlool AW, AlBattal NZ, et al. Lipedema: Clinical Features, Diagnosis, and Management. Arch Plast Surg. 2025;52(3):185-196.

van la Parra RFD, Deconinck C, Pirson G, Servaes M, Fosseprez P. Lipedema: What we don't know. J Plast Reconstr Aesthet Surg. 2023;84:302-312.

Katzer K, Hill JL, McIver KB, Foster MT. Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation. Int J Mol Sci. 2021;22(21):11720.

Klimentidis YC, Chen Z, Gonzalez-Garay ML, et al. Genome-wide association study of a lipedema phenotype among women in the UK Biobank identifies multiple genetic risk factors. Eur J Hum Genet. 2023;31(3):338-344.

Herbst KL. Rare adipose disorders (RADs) masquerading as obesity. Acta Pharmacol Sin. 2012;33(2):155-172.

Paolacci S, Precone V, Acquaviva F, et al. Genetics of lipedema: new perspectives on genetic research and molecular diagnoses. Eur Rev Med Pharmacol Sci. 2019;23(13):5581-5594.

Luchinger JE, Pavicic E, Giachino CL, Stute P. Impact of hormones on lipedema development: a systematic literature review. Arch Gynecol Obstet. 2026;313(1):60.

Michelini S, Chiurazzi P, Marino V, et al. Aldo-Keto Reductase 1C1 (AKR1C1) as the First Mutated Gene in a Family with Nonsyndromic Primary Lipedema. Int J Mol Sci. 2020;21(17):6264.

Bano G, Mansour S, Brice G, et al. Pit-1 mutation and lipoedema in a family. Exp Clin Endocrinol Diabetes. 2010;118(6):377-380.

Precone V, Barati S, Paolacci S, et al. Genetic syndromes with localized subcutaneous fat tissue accumulation. Acta Biomed. 2019;90(Suppl 10):90-92.

Zechner U, Kohlschmidt N, Kempf O, et al. Familial Sotos syndrome caused by a novel missense mutation, C2175S, in NSD1 and associated with normal intelligence, insulin dependent diabetes, bronchial asthma, and lipedema. Eur J Med Genet. 2009;52(5):306-310.

Waxler JL, Guardino C, Feinn RS, Lee H, Pober BR, Stanley TL. Altered body composition, lipedema, and decreased bone density in individuals with Williams syndrome: A preliminary report. Eur J Med Genet. 2017;60(5):250-256.

Michelini S, Herbst KL, Precone V, et al. A Multi-Gene Panel to Identify Lipedema-Predisposing Genetic Variants by a Next-Generation Sequencing Strategy. J Pers Med. 2022;12(2):268.

Grigoriadis D, Sackey E, Riches K, et al. Investigation of clinical characteristics and genome associations in the ‘UK Lipoedema’cohort. PLoS ONE. 2022;17(10):e0274867. doi: 10.1371/journal.pone.0274867.

Faria AM, Valerio CM, Barcellos CR, et al. Unraveling lipedema: comprehensive insights and the path to future discoveries. npj Metab Health Dis. 2026;4(1):3.

Tomada I. Lipedema: From Women’s Hormonal Changes to Nutritional Intervention. Endocrines. 2025;6(2):24.

Bertlich M, Jakob M, Bertlich I, Schift R, Bertlich R. Lipedema in a male patient: report of a rare case–management and review of the literature. GMS Interdiscip Plast Reconstr Surg DGPW. 2021;10:Doc11. doi: 10.3205/iprs000161.

Pinto da Costa Viana D, Caseri Câmara L, Borges Palau R. Menopause as a critical turning point in lipedema: the estrogen receptor imbalance, intracrine estrogen, and adipose tissue dysfunction model. Int J Mol Sci. 2025;26(15):7074.

Ahmed F, Kamble PG, Hetty S, et al. Role of Estrogen and Its Receptors in Adipose Tissue Glucose Metabolism in Pre- and Postmenopausal Women. J Clin Endocrinol Metab. 2022;107(5):e1879-e1889. doi: 10.1210/clinem/dgac042.

Viana DPdC, Câmara LC. Hormonal Links between Lipedema and Gynecological Disorders: Therapeutic Roles of Gestrinone and Drospirenone. J Adv Med Med Res. 2025;37(2):175-188.

Strohmeier K, Hofmann M, Jacak J, et al. Multi-Level Analysis of Adipose Tissue Reveals the Relevance of Perivascular Subpopulations and an Increased Endothelial Permeability in Early-Stage Lipedema. Biomedicines. 2022;10(5):1163.

Connolly S. Does lipoedema mimic pregnancy. J Lymphoedema. 2022;17(1):19.

Laur G. Fat Metabolism and Dysfunction in Lipedema. In Laur G, editor. Lipoedema: Voices of Resilience: Cham: Springer; 2025. p. 33-44.

Viana D, Invitti AL, Schor E. Tirzepatide as a Potential Disease-Modifying Therapy in Lipedema: A Narrative Review on Bridging Metabolism, Inflammation, and Fibrosis. Int J Mol Sci. 2025;26(21):10741.

Al-Ghadban S, Diaz ZT, Singer HJ, Mert KB, Bunnell BA. Increase in Leptin and PPAR-gamma Gene Expression in Lipedema Adipocytes Differentiated in vitro from Adipose-Derived Stem Cells. Cells. 2020;9(2):430.

Bauer AT, von Lukowicz D, Lossagk K, et al. Adipose Stem Cells from Lipedema and Control Adipose Tissue Respond Differently to Adipogenic Stimulation In Vitro. Plast Reconstr Surg. 2019;144(3):623-632.

Felmerer G, Stylianaki A, Hägerling R, et al. Adipose Tissue Hypertrophy, An Aberrant Biochemical Profile and Distinct Gene Expression in Lipedema. J Surg Res. 2020;253:294-303.